營 銷：0534-2623181 0534-2623132
Dezhou Deyao Pharmaceutical Co., Ltd., former Dezhou Pharmaceutical
Factory in Shandong Province, was founded in 1971. It is a comprehensive
modern pharmaceutical enterprise integrating research, production and sales.
In 2012, the company relo cated to Dezhou Economic and Technological
Development Zone. According to the requirements of the new version of GMP,
the new factory covering an area of 200 mu was built. It has complete equipment and facilities from API to preparations, and a specialized R&D, production
and sales team.
The company adheres to the direction of specialized, refined, particular and
innovative enterprise development. Specialty: focus on the development
direction of cardiovascular and cerebrovascular drugs and anti-tumor drugs.
Refining: specialize in the sustained and controlled release preparation
technology and freeze-drying preparation technology. Particular: either the first,
or the unique, to be the first in the national sales volume and the only exclusive
product in the country. Innovation: innovative and high-quality development.
Focusing on the management of cardiovascular and cerebrovascular drugs, anti-tumor drugs, large market volume drugs, the three business
divisions have formed a three-in-one trend and sales network proliferates the country.
The company's core products: Caffeic acid Tablets, the world's exclusive patented chemical drugs, clinical use for platelet-raising, leucocyte
raising and hemostasis, is the unique domestic evidence-based medicine research support for the maintenance treatment of mild
thrombocytopenia preferred oral chemical drugs. We devote to creating the Chinese first brand of blood system medicine.
Degaoning (10mg Nifedipine Sustained-release Tablets) used imported sustained-release excipients is to create the clinical commonly used
antihypertensive drugs preferred brand. As the first generic drug in china, because of its sustained-release long-term, it has proved better
efficacy and hold the biggest margins. The company is in the process of transforming and upgrading from slow-release technology to
controlled-release technology, and implementing the transformation of old and new driving forces to form a product group of controlled-release
products in the field of cardiovascular and cerebrovascular diseases.
Yisong (Azithromycin Fumarate Tablets), the world's exclusive patent drugs, new water-soluble macrolides antibiotics, is an oral drugs to treat
respiratory and urinary tract infections. It has the equal curative effect to infusion. Especially for the cold and fever caused by a variety of
inflammation, the effect is fast. The disease can be cured by oral cure for three days.
Pemetrexed disodium for injection, a national patented product with advanced technology, is a high-end product for the treatment of lung cancer
and malignant pleural mesothelioma. Esomeprazole Sodium for Injection,the newly lanched product with national patent, is the key special
project blockbuster of Department of Science & Technology of Shandong province for the treatment of gastric ulcers.
The company has strong scientific and technological innovation ability, is the National High-Technology Enterprise, National New Medicine
Research Platform Demonstration Enterprises, Provincial Enterprise Technology Center, Drug Osmotic Pump Engineering Research Center,
Postdoctoral Innovation Practice Base, Dezhou medicine industry leading enterprises alliance, Dezhou key "escort" for the development of
enterprises, and has won the Tax-Paying Meritorious Enterprise for multiple consecutive years.
The company insists on three kinds of treatment: "Treat the society well, treat the employees well and treat the shareholders well". It strives to
improve the operation quality of the enterprise, fulfill the social responsibility , and has been awarded as the Tax-Paying Advanced Enterprise of
Dezhou for multiple consecutive years. Bian Jiangang, chairman of the board with a special allowance from the state council, was elected as a
deputy to the Shandong Provincial People's Congress.
Adhering to the business philosophy of " Make good medicine by our conscience, Improve people's health by our medicine", the company strives
to achieve transformation and upgrading and high-quality development. It has become an excellent pharmaceutical enterprise recognized by the
government, respected by the society and praised by the public. We must undertake the mission of curing diseases, alleviating suffering and
improving the quality of life. The company will undertake the mission of curing diseases, alleviating suffering and improving the quality of life and
strive to become one of the top 100 enterprises in the pharmaceutical industry, make the century dream of Deyao come true.